Company Performance: Strong earnings, revenue growth, and positive future guidance typically drive the stock price higher, while losses or declining growth can negatively impact it.

Industry Trends: The overall health and outlook of the pharmaceutical industry influence investor sentiment. Positive developments, such as new drug approvals or expanding market opportunities, can lift the stock.

Market Sentiment: General market conditions, including economic growth, interest rates, and inflation, play a role. Bullish market sentiment often benefits most stocks, while bearish sentiment can pressure prices.

Regulatory Changes: Changes in pharmaceutical regulations, such as drug pricing policies or approval processes, can have a significant impact on the company's profitability and therefore its stock price.

Competition: The competitive landscape, including the emergence of new competitors or the launch of rival products, can influence investor perception of the company's market share and future prospects.

Economic Data: Macroeconomic indicators like GDP growth, inflation rates, and unemployment figures can indirectly impact the stock. Strong economic growth can boost demand for healthcare products, while high inflation can erode profitability.

Currency Exchange Rates: Fluctuations in currency exchange rates, particularly between the British pound and other major currencies, can impact the company's revenue and earnings, especially if it has significant international operations.

Investor Confidence: Overall investor confidence in the company's management, strategy, and long-term prospects can influence the stock price. Positive analyst ratings and institutional ownership can boost confidence.

Global Events: Unforeseen global events, such as pandemics or geopolitical instability, can disrupt supply chains, affect demand, and create uncertainty, impacting stock prices across various sectors, including pharmaceuticals.